A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Polycystic Ovary Syndrome
Clinical trial NCT06595797 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06595797
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-12-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.